Law Offices of Howard G. Smith Announces Class Action Lawsuit against American Oriental Bioengineering, Inc.

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of a class comprising all persons who purchased or otherwise acquired the securities of American Oriental Bioengineering, Inc. (“AOBI” or the “Company”) (OTC: AOBI) between November 9, 2009 and June 15, 2012, inclusive (the “Class Period”).

AOBI engages in the development, manufacture and commercialization of pharmaceutical and healthcare products. The Complaint alleges that the defendants made false and misleading statements and/or failed to disclose material adverse facts about AOBI’s operations and financial performance. Specifically, defendants misrepresented and/or failed to disclose that: (1) certain of the Company’s capsule products maintained chrome levels far exceeding humanly tolerable limits; (2) the Company’s financial statements contained material inconsistencies; (3) the Company’s internal controls over financial reporting were deficient; and (4), as a result of the foregoing, the Company’s statements were materially false and misleading at all relevant times.

No class has yet been certified in the above action. Until a class is certified, you are not represented by counsel unless you retain one. If you purchased AOBI securities between November 9, 2009 and June 15, 2012, you have certain rights, and have until August 22, 2012 to move for lead plaintiff status. To be a member of the class you need not take any action at this time, and you may retain counsel of your choice. If you wish to discuss this action or have any questions concerning this Notice or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at http://www.howardsmithlaw.com.

American Oriental Bioeng... (CE) (USOTC:AOBI)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024